Incannex Healthcare Limited

General ticker "IXHL" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $19.6M (TTM average)

Incannex Healthcare Limited does not follow the US Stock Market performance with the rate: -10.2%.

Estimated limits based on current volatility of 10.7%: low 2.95$, high 4.43$

Factors to consider:

  • Total employees count: 5 as of 2022
  • Current price 86.4% below estimated low
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [47.72$, 169.21$]
  • 2025-06-30 to 2026-06-30 estimated range: [24.39$, 95.94$]

Financial Metrics affecting the IXHL estimates:

  • Negative: with PPE of -25.6 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -3.01 <= 0.01
  • Positive: Investing cash flow per share per price, % of -0.05 > -0.63
  • Positive: Shareholder equity ratio, % of 65.80 > 64.29
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term IXHL quotes

Long-term IXHL plot with estimates

Financial data

YTD 2022-06-30 2023-06-30 2024-06-30
Operating Revenue $0.00MM $0.00MM $0.02MM
Operating Expenses $10.16MM $13.64MM $44.99MM
Operating Income $-10.16MM $-13.64MM $-44.97MM
Non-Operating Income $-0.09MM $-35.17MM $17.38MM
R&D Expense $3.70MM $6.31MM $19.28MM
Income(Loss) $-10.25MM $-48.81MM $-27.59MM
Taxes $0.00MM $0.00MM $0.04MM
Profit(Loss)* $-10.25MM $-48.81MM $-18.46MM
Stockholders Equity $24.76MM $20.82MM $11.22MM
Assets $26.15MM $23.78MM $17.05MM
Operating Cash Flow $-8.84MM $-10.75MM $-15.85MM
Capital expenditure $0.00MM $0.32MM $0.28MM
Investing Cash Flow $0.00MM $-0.32MM $-0.28MM
Financing Cash Flow $28.33MM $9.00MM $0.14MM
Earnings Per Share** $-1.03 $-9.52 $-3.43

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.